Recently, the first PSP GWAS17 discovered three non-MAPT susceptibility loci at STX6, EIF2AK3, and MOBP, raising the possibility that additional non-MAPT genetic risk factors or modifiers may also exist for CBD. This evidence concerns the gene MOBP and supranuclear palsy, progressive, 1.